Elevated Levels of Prostate-Specific Antigen in Serum of Women With Fibroadenomas and Breast Cysts
Open Access
- 16 April 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (8) , 587-588
- https://doi.org/10.1093/jnci/89.8.587
Abstract
Prostate-specific antigen (PSA) is a valuable serum marker for diagnosis and monitoring of prostate cancer. In males, the reference range is about 1-2 ng, and values above 3-4 ngare indicative of either prostate cancer, benign prostatic hyperplasia, or prostatitis. Women have no prostate, and levels of PSA in female serum should be very low or undetectable. Many recent reports, however, confirm that PSA is produced in the female breast (1). A relatively large study examined the levels of PSA in female serum and confirmed that, among serum samples from 1064 women, the highest concentration observed was 0.9 ng. The median PSA in normal women is about 0.002 ng(2). Women with hyperandrogenic syndromes may have levels up to 0.6 ng.Keywords
This publication has 2 references indexed in Scilit:
- Prostate specific antigen in breast cancer, benign breast disease and normal breast tissueBreast Cancer Research and Treatment, 1996
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new eraUrology, 1995